Abstract:Abstract Loss-of-function mutations have provided crucial insights into the immunoregulatory actions of Foxp3+ regulatory T cells (Tregs). By contrast, we know very little about the consequences of defects that amplify aspects of Treg function or differentiation. Here we show that mice heterozygous for an Ikbkb gain-of-function mutation develop psoriasis. Doubling the gene dose ( Ikbkb GoF/GoF ) results in dactylitis, spondylitis, and characteristic nail changes, which are features of psoriatic arthritis. Ikbkb GoF mice exhibit a selective expansion of Foxp3 + CD25+ Tregs of which a subset express IL-17. These modified Tregs are enriched in both inflamed tissues, blood and spleen, and their transfer is sufficient to induce disease without conventional T cells. Single-cell transcriptional and phenotyping analyses of isolated Tregs reveal expansion of non-lymphoid tissue (tissue-resident) Tregs expressing Th17-related genes, Helios, tissue-resident markers including CD103 and CD69, and a prominent NF-κB transcriptome. Thus, IKK2 regulates tissue-resident Treg differentiation, and overactivity drives dose-dependent skin and systemic inflammation.

What problem does this paper attempt to address?

The paper primarily explores the role of IKK2 (IκB kinase 2) in regulating the function of tissue-resident regulatory T cells (Tregs) and investigates the impact of gain-of-function mutations in IKK2 on skin inflammation and systemic inflammation through the construction of mouse models. Specifically, the paper addresses the following key issues: 1. **The relationship between IKK2 gain-of-function mutations and skin inflammation**: Researchers found that mice carrying IKK2 gain-of-function mutations (IkbkbGoF) develop skin inflammation similar to human psoriasis, including features such as epidermal thickening and infiltration of inflammatory cells. This mutation also leads to the occurrence of arthritis, similar to human psoriatic arthritis. 2. **The impact of IKK2 on Tregs differentiation**: The study reveals the role of IKK2 in regulating the differentiation of Tregs into tissue-resident Tregs. Tissue-resident Tregs are a special subtype of Tregs that reside in non-lymphoid tissues and participate in immune regulation and tissue homeostasis maintenance. When IKK2 activity is excessively high, these Tregs may be driven to transform into effector cell-like functions, thereby losing their normal inhibitory function and promoting inflammatory responses. 3. **The emergence of IL-17 producing Tregs**: The paper points out that the gain-of-function mutation in IKK2 leads to a significant expansion of a subset of Tregs expressing IL-17 in mice. These IL-17+ Tregs are enriched in sites of skin inflammation and other inflammatory tissues and can transfer and induce disease even in the absence of conventional T cells. In summary, this study, by constructing a mouse model with IKK2 gain-of-function mutations, not only reveals the important role of IKK2 in Tregs differentiation but also discovers the mechanism by which hyperactive IKK2 leads to the occurrence of skin and systemic inflammation. This provides a new perspective for understanding the occurrence of autoimmune diseases and may provide a theoretical basis for the development of future therapeutic strategies.

IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model

Rkip Mediates Autoimmune Inflammation By Positively Regulating Il-17r Signaling

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1

Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells

Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease

MINK1 Kinase Suppresses TH17 Differentiation and Autoimmune Inflammation Via Inhibition of the TGF-β Pathway

IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses

Loss of T follicular regulatory cell–derived IL-1R2 augments germinal center reactions via increased IL-1

Medullary Thymic Epithelial NF-kB-inducing Kinase (nik)/ikkα Pathway Shapes Autoimmunity and Liver and Lung Homeostasis in Mice.

Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells

TGF-beta-dependent Suppressive Function of Tregs Requires Wild-Type Levels of CD18 in a Mouse Model of Psoriasis.

A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

IKKβ increases neuropilin-2 and promotes the inhibitory function of CD9+ Bregs to control allergic diseases

Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation

Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation

FOXP3 exon 2 controls T reg stability and autoimmunity

The Role of Tyrosine Kinase Itk in T helper 17 and T regulatory cells in Hypersensitivity Pneumonitis

IRAK2 deficiency causes a new immune dysregulation disorder

Dendritic Cell-Specific Disruption of TGF-β Receptor II Leads to Altered Regulatory T Cell Phenotype and Spontaneous Multiorgan Autoimmunity.